SCIg for CIDP: What I Learned About This Treatment Option

I live with Lewis–Sumner syndrome, a rare variant of CIDP, so treatments like SCIg aren’t just abstract concepts to me—they’re part of my real, everyday life.

In this post, I wanted to gather everything I’ve learned about SCIg in one place, specifically for people who are trying to understand this treatment option without feeling overwhelmed.

I’ve written about many different CIDP-related topics on this blog, but this post is intentionally only about SCIg.

No extra noise, no side quests—just straightforward, practical information about this one treatment method.

My goal is to answer some of the most common questions and anxieties that come up again and again in CIDP support groups, especially for those who are new to SCIg or considering the switch from IVIg.

The information here is based on what I’ve learned from various reputable medical and patient-education sources (you’ll find all the links at the end of the post), along with insights shaped by lived experience.

Think of this as me doing the rummaging through dense medical pages so you don’t have to.

Of course, if you want to go down the rabbit hole yourself—knock yourself out.

The sources are there for you to explore.

This is meant to be a short, practical guide—something you can read in one sitting and walk away feeling a little more informed and a little less anxious.

What Is SCIg (Subcutaneous Immunoglobulin)?

Subcutaneous Immunoglobulin (SCIg) is a treatment option for CIDP where immunoglobulin (IgG) is delivered under the skin instead of into a vein.

Like IVIg, SCIg provides antibodies that help regulate the immune system and calm down nerve inflammation. The main difference is how the medication gets into your body.

How SCIg Works

With SCIg, IgG is absorbed slowly from the tissue under the skin into the bloodstream. This steady, gradual release helps keep antibody levels more stable over time.

For many people, this means fewer “peaks and crashes” compared to IVIg—and often fewer whole-body side effects.

Another big plus?

SCIg can usually be self-administered at home, which gives people more flexibility and independence in managing their treatment.

Who Is SCIg For?

SCIg is approved as a maintenance treatment for adults with CIDP—especially for those who are already stable on IVIg. In some cases, it may also be used for newly diagnosed patients.

It can be a great option for people who:

Have difficult or painful venous access
Experience side effects with IV infusions
Prefer home-based treatment instead of clinic visits

Switching from IVIg to SCIg isn’t one-size-fits-all.

The dose usually needs to be adjusted, and doctors monitor how well symptoms are controlled during the transition.

Common Side Effects

The most common side effects with SCIg are local injection site reactions, such as:

Redness
Swelling
Itching
Tenderness or mild discomfort

These reactions are usually mild to moderate and tend to improve over time as your body gets used to the treatment.

Whole-body side effects like headaches or fatigue can still happen, but they’re generally less common than with IVIg.

Good injection technique and rotating injection sites can really help reduce discomfort.

The Big Picture

SCIg is a convenient and effective alternative to IVIg for long-term CIDP management. It offers steadier immunoglobulin levels, fewer systemic side effects for many people, and the flexibility of at-home treatment.

While local site reactions are the most common downside, they’re usually manageable—and for many patients, the trade-off is well worth the added independence.

Typical SCIg dosing schedules and how to switch from IVIg

Typical dosing schedules for Subcutaneous Immunoglobulin (SCIg) in CIDP typically range from weekly to biweekly administrations.

The exact dose depends on the patient’s previous IVIg dose, clinical response, and body weight.

Still, a common approach is to use a cumulative monthly dose equivalent to the patient’s total monthly IVIg dose, divided into smaller, more frequent SCIg doses.

For example, if a patient received 2 grams/kg of IVIg monthly, this dose is often split into weekly doses of approximately 0.5 grams/kg of SCIg.

Switching from IVIg to SCIg usually involves calculating an equivalent total monthly dose and redistributing it into weekly or biweekly SCIg infusions.

The transition is often smooth, but clinicians closely monitor symptoms and adjust doses as needed to maintain disease control.

During the switch, some patients may overlap treatments briefly or require dose titration based on their tolerance and clinical effectiveness.

Patient education on self-administration technique, site rotation, and managing mild local reactions is essential for a successful switch.

In sum, SCIg dosing schedules are individualized, commonly weekly or biweekly, mirroring the prior IVIg dose split into smaller subcutaneous infusions.

Careful monitoring and dose adjustments help ensure stable disease management during the IVIg to SCIg transition.

How to Store SCIg

Subcutaneous immunoglobulin (SCIg) is usually stored at room temperature (up to 25°C / 77°F).

It’s stable for a long time (often up to 30 months), but it should always be kept in its original packaging and away from direct light.

Translation: don’t leave it in the sun, don’t store it somewhere super hot, and don’t transfer it to random containers.

(I just want to add that I got a special cooler to transport and store the Ig at home.)

Vaccines, Tests & Medication Interactions

SCIg can interfere with how well some live vaccines work (like measles, mumps, rubella, and chickenpox).

If you’re planning to get vaccinated, make sure your doctor knows you’re on SCIg (or have recently received it).

It can also mess with some blood test results because it contains antibodies.

So if you’re getting lab work done, it’s a good idea to remind your healthcare team that you’re on immunoglobulin therapy.

Who Should NOT Use SCIg

SCIg isn’t for everyone. It’s not recommended for people who have had a severe allergic reaction to immunoglobulin in the past, or to any of the ingredients used in SCIg (like polysorbate 80).

It’s also not recommended for people with:

Certain rare metabolic conditions (like hyperprolinemia type 1 or 2)
IgA deficiency with antibodies against IgA (this can increase the risk of severe allergic reactions)

If any of this applies to you, this is definitely a “talk to your doctor first” situation.

Important Warnings & Things to Watch For

Allergic Reactions

SCIg can, in rare cases, cause serious allergic reactions.

If someone develops symptoms like trouble breathing, swelling of the face or throat, hives, or sudden dizziness, the infusion should be stopped right away and medical help is needed.

People with IgA deficiency are at higher risk for severe reactions, which is why doctors screen carefully for this.

Blood Clots (Yes, This Is the Black Box Warning)

All immunoglobulin products (including SCIg) come with a warning about blood clots. The risk is higher if you have factors like:

A history of blood clots
Heart or circulation issues
Blood that’s already “thicker” than normal
Limited mobility
Use of estrogen (like some birth control or hormone therapy)

To lower the risk, doctors usually recommend:

Staying well hydrated
Using the lowest effective dose
Not infusing too fast

Aseptic Meningitis (Rare, But Scary-Sounding)

This can happen within hours to a couple of days after treatment. Symptoms may include:

Severe headache
Stiff neck
Fever
Sensitivity to light
Nausea or vomiting

It’s rare, but worth knowing about so you don’t ignore serious symptoms.

Kidney Issues

In some people, immunoglobulin treatments can affect kidney function.

This is more of a concern if you already have kidney problems or are at higher risk.

Doctors usually monitor kidney function with blood tests (like creatinine and BUN), especially at the start of treatment.

Hydration matters here too—being well-hydrated before infusions can help reduce the risk.

Lungs, Blood, and Infection Risks

SCIg can very rarely cause:

Lung-related issues (like non-cardiogenic pulmonary edema)
Breakdown of red blood cells (hemolysis), which can lead to anemia
Transmission of infections (even though products are screened and treated, the risk is never zero)

If someone has breathing problems after SCIg, oxygen may be needed.

If there are signs of anemia (like extreme fatigue, pale skin, shortness of breath), blood tests are usually done to check what’s going on.

Common Side Effects (What People Actually Report)

In studies, the most commonly reported side effects were:

Local reactions at the injection site (redness, swelling, itching, soreness)
Headache
Fatigue
Nausea or vomiting
Diarrhea
Back or joint pain
Rash or itching
Migraine
Cold-like symptoms (runny nose, sore throat, mild infections)

Most of these are on the milder side and tend to improve over time as the body gets used to SCIg.

Still, everyone’s experience is different—which is why side effects are such a hot topic in support groups.

So what do you think?

Think of this as me doing the rummaging through dense medical pages so you don’t have to.

Of course, if you want to go down the rabbit hole yourself—knock yourself out.

The sources are there for you to explore.

I’ll end here without adding personal anecdotes, to keep things clear and focused.

If you’re currently wondering whether switching from IVIg to SCIg might be right for you—or for someone you care about—I hope this post has given you a calmer, clearer place to start thinking it through.

If you have questions, feel unsure, or are wrestling with this decision and think I might be able to help, you’re very welcome to ask.

Just reach out – You don’t have to figure this out alone.

CIDP + Alone is hard!

Disclaimer: I want to acknowledge that I am not a medical authority; I am a CIDP warrior looking for answers like you, reading this post. I use various internet sources to learn and my own experience to verify. Please always ask your doctors, physical therapist, and nurses what’s best for you because not everything I share here will work or resonate with you.

Sharing is caring – if this supported you in any small way, sharing it may support someone else with CIDP, and subscribing keeps this circle of healing and awareness growing.

SOURCES:

SCIg for CIDP Explained: What It Is, How It Works, and What to Expect